Kim Y - Search Results

1

Quantitative Temporal in Vivo Proteomics Deciphers the Transition of Virus-Driven Myeloid Cells into M2 Macrophages.

Clements DR, Murphy JP, Sterea A, Kennedy BE, Kim Y, Helson E, Almasi S, Holay N, Konda P, Paulo JA, Sharif T, Lee PW, Weekes MP, Gygi SP, Gujar S. Clements DR, et al. Among authors: kim y. J Proteome Res. 2017 Sep 1;16(9):3391-3406. doi: 10.1021/acs.jproteome.7b00425. Epub 2017 Aug 23. J Proteome Res. 2017. PMID: 28768414 Free PMC article.

2

Newly recruited CD11b+, GR-1+, Ly6C(high) myeloid cells augment tumor-associated immunosuppression immediately following the therapeutic administration of oncolytic reovirus.

Clements DR, Sterea AM, Kim Y, Helson E, Dean CA, Nunokawa A, Coyle KM, Sharif T, Marcato P, Gujar SA, Lee PW. Clements DR, et al. Among authors: kim y. J Immunol. 2015 May 1;194(9):4397-412. doi: 10.4049/jimmunol.1402132. Epub 2015 Mar 30. J Immunol. 2015. PMID: 25825443

3

Dendritic Cells in Oncolytic Virus-Based Anti-Cancer Therapy.

Kim Y, Clements DR, Sterea AM, Jang HW, Gujar SA, Lee PW. Kim Y, et al. Viruses. 2015 Dec 9;7(12):6506-25. doi: 10.3390/v7122953. Viruses. 2015. PMID: 26690204 Free PMC article. Review.

4

All that glitters is not gold: the need to consider desirable and undesirable immune aspects of oncolytic virus therapy.

Clements DR, Kim Y, Gujar SA, Lee PW. Clements DR, et al. Among authors: kim y. Oncoimmunology. 2015 Jun 5;5(1):e1057674. doi: 10.1080/2162402X.2015.1057674. eCollection 2016. Oncoimmunology. 2015. PMID: 26942069 Free PMC article.

5

NAD⁺ salvage pathway in cancer metabolism and therapy.

Kennedy BE, Sharif T, Martell E, Dai C, Kim Y, Lee PW, Gujar SA. Kennedy BE, et al. Among authors: kim y. Pharmacol Res. 2016 Dec;114:274-283. doi: 10.1016/j.phrs.2016.10.027. Epub 2016 Nov 2. Pharmacol Res. 2016. PMID: 27816507 Review.

6

Autophagic homeostasis is required for the pluripotency of cancer stem cells.

Sharif T, Martell E, Dai C, Kennedy BE, Murphy P, Clements DR, Kim Y, Lee PW, Gujar SA. Sharif T, et al. Among authors: kim y. Autophagy. 2017 Feb;13(2):264-284. doi: 10.1080/15548627.2016.1260808. Epub 2016 Dec 8. Autophagy. 2017. PMID: 27929731 Free PMC article.

7

MHC-I Ligand Discovery Using Targeted Database Searches of Mass Spectrometry Data: Implications for T-Cell Immunotherapies.

Murphy JP, Konda P, Kowalewski DJ, Schuster H, Clements D, Kim Y, Cohen AM, Sharif T, Nielsen M, Stevanovic S, Lee PW, Gujar S. Murphy JP, et al. Among authors: kim y. J Proteome Res. 2017 Apr 7;16(4):1806-1816. doi: 10.1021/acs.jproteome.6b00971. Epub 2017 Mar 21. J Proteome Res. 2017. PMID: 28244318 Free article.

8

Sharpening the Edge for Precision Cancer Immunotherapy: Targeting Tumor Antigens through Oncolytic Vaccines.

Holay N, Kim Y, Lee P, Gujar S. Holay N, et al. Among authors: kim y. Front Immunol. 2017 Jul 13;8:800. doi: 10.3389/fimmu.2017.00800. eCollection 2017. Front Immunol. 2017. PMID: 28751892 Free PMC article. Review.

9

Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies.

Gujar S, Pol JG, Kim Y, Lee PW, Kroemer G. Gujar S, et al. Among authors: kim y. Trends Immunol. 2018 Mar;39(3):209-221. doi: 10.1016/j.it.2017.11.006. Epub 2017 Dec 20. Trends Immunol. 2018. PMID: 29275092 Review.

10

Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis.

Warford JR, Lamport AC, Clements DR, Malone A, Kennedy BE, Kim Y, Gujar SA, Hoskin DW, Easton AS. Warford JR, et al. Among authors: kim y. Acta Neuropathol Commun. 2018 Jan 4;6(1):4. doi: 10.1186/s40478-017-0506-9. Acta Neuropathol Commun. 2018. PMID: 29301568 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85,825 results

Search Page

Filters